Iron Deficiency Anemia – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Iron Deficiency Anemia - Pipeline Review, H2 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the thera
|
$ 2000
|
|
|
Renal Anemia – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Renal Anemia - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development f
|
$ 2000
|
|
|
Chemotherapy Induced Anemia – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Chemotherapy Induced Anemia - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on
|
$ 2000
|
|
|
Anemia – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Anemia - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Anemia, c
|
$ 2000
|
|
|
Aplastic Anemia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Aplastic Anemia - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic develop
|
$ 2000
|
|
|
Fanconi Anemia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Fanconi Anemia - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic developme
|
$ 2000
|
|
|
Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report p
|
$ 2000
|
|
|
Iron Deficiency Anemia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Iron Deficiency Anemia - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the thera
|
$ 2000
|
|
|
Renal Anemia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Renal Anemia - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development f
|
$ 2000
|
|
|
Chemotherapy Induced Anemia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Chemotherapy Induced Anemia - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report provides information on
|
$ 2000
|
|
|
Anemia – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Anemia - Pipeline Review, H2 2012'', provides an overview of the Anemia therapeutic pipeline. This report provides information on the therapeutic development for Anemia, complet
|
$ 2000
|
|
|
Aplastic Anemia Global Clinical Trials Review, H2, 2012
Summary
GlobalData''s clinical trial report, “Aplastic Anemia Global Clinical Trials Review, H2, 2012" provides data on the Aplastic Anemia clinical trial scenario. This report provides ele
|
$ 2500
|
|
|
Report SummaryGlobalData, the industry analysis specialist, has released its new report, Sickle Cell Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2018”. The report is an essential source of...
|
$ 3500
|
|
|
GlobalData, the industry analysis specialist, has released its new report, ”. The report is an essential source of information...
|
$ 3500
|
|
|
GlobalData, the industry analysis specialist, has released its new report, ”. The report is an essential source of information and analysis on t...
|
$ 2000
|
|
|
Report Description:Life Science Analytics', Anemia Therapy Area Pipeline Report contains detailed information on the anemia drug pipeline. This report provides insight into the pipeline status of anemia drugs by company...
|
$ 1501
|
|
|